Bioline Of Israel, Genoscience Of France To Co-Develop Hep C Drug
This article was originally published in PharmAsia News
Executive Summary
Israel’s Bioline RX and France’s Genoscience have agreed to co-develop and market hepatitis C drug BL-8020 discovered by Genoscience co-founder and President Philippe Halfon.